-
How Can Foreign F&B Brands Enter China? Food Franchising Models and Market Entry Considerations
Foreign food and beverage chains are expanding in China through franchising and local capital. We compare the entry models open to foreign F&B brands and the compliance steps that determine success.
-
China’s Food Franchising Market in 2026: US Chains Return as the Industry Consolidates
US food chain brands are entering or re-entering China at the fastest pace in years, relying on franchising and local capital partners to expand in a RMB 5.8 trillion (US$833.8 billion) catering market that is growing more slowly but consolidating rapidly around chains. We examine the data behind the trend.
-
Where to Invest in China: Priority Industries by Province
China's provincial 15th Five-Year Plans reveal where the country's industrial priorities are heading over the next five year, revealing new opportunities for foreign investors.
-
Where to Invest in China in the Next Five Years – Analysing Four Priority High-Tech Sectors
China’s provincial 15th Five-Year Plans highlight four investment opportunities: green hydrogen, embodied AI, semiconductors, and biomanufacturing. We examine the leading regions and key considerations for foreign investors.
-
China’s Manufacturing Advantage Beyond Subsidies
As China curbs local subsidy competition, its manufacturing advantage is increasingly rooted in industrial ecosystems, supply chain integration, operational speed, and infrastructure quality rather than direct incentives.
-
Investing in Shanghai’s AI Investment Clusters: Where the Opportunities Lie After WAIC 2026
We map Shanghai's key AI investment clusters (Xuhui, Zhangjiang, and Lingang) and explain where foreign investors should consider landing after WAIC 2026.
-
Where to Invest in China’s Biopharma Boom: Mapping the Big Three Clusters in 2026
China now generates close to a third of the world’s innovative-drug pipeline, and foreign multinationals are committing billions to specific addresses. We map where the capital is going, and why each of China’s three anchor life sciences clusters suits a different kind of investor.
-
China Clarifies Medical Device Classification for Brain-Computer Interfaces: A Guide for Foreign Investors
NMPA's new guideline sorts BCI devices into concrete risk classes and registration pathways, turning what used to be a regulatory guessing game into a roadmap foreign investors can actually plan around. Find out which devices get the fast-track Class II route, which face the full Class III gauntlet, and what it all means for your China market entry strategy.